Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
Related Posts
Milky Mist IPO fully subscribed on day 2, led by NIIs; GMP at 17%
The company’s IPO garnered bids for 12,41,78,850 shares against 8,17,98,244 shares on offer, as per BSE data.
J.P. Morgan raises Novo Nordisk target on stronger Ozempic, Wegovy sales
J.P. Morgan raises Novo Nordisk target on stronger Ozempic, Wegovy sales
Mid, smallcaps likely to outperform in September; Nifty seen range-bound: Analysts
September historically favors mid- and small-cap stocks over large-caps. Analysts anticipate this trend continuing, expecting limited upside for the Nifty. Heavyweight sectors show recent weakness, and foreign investor selling has resumed. Domestic fund flows remain concentrated in mid- and small-cap stocks. Market action is expected to remain stock-specific until fresh triggers emerge.